Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

INSANE: Benzinga s top ratings upgrades downgrades for october 3 2022 - The Real Truth

Upgrades

For Sensei Biotherapeutics Inc (NASDAQ:SNSE), Oppenheimer upgraded the previous rating of Perform to Outperform. For the second quarter, Sensei Biotherapeutics had an EPS of $0.34, compared to year-ago quarter EPS of $0.32. The current stock performance of Sensei Biotherapeutics shows a 52-week-high of $6.17 and a 52-week-low of $1.45. Moreover, at the end of the last trading period, the closing price was at $1.55.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.